Natera to Report its First Quarter 2024 Results on May 9
Earnings Conference Call Information:
Event: |
Natera’s First Quarter 2024 Financial Results |
Date: |
Thursday, May 9, 2024 |
Time: |
1:30 p.m. PT (4:30 p.m. ET) |
Live Dial-In: |
1 (888) 770-7321 (Domestic) |
|
1 (929) 201-7107 (International) |
Conference ID: |
7684785 |
Webcast: |
|
A webcast replay will be available at investor.natera.com. |
About Natera
Natera™ is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard-of-care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are supported by more than 200 peer-reviewed publications that demonstrate excellent performance. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in
View source version on businesswire.com: https://www.businesswire.com/news/home/20240501877493/en/
Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-405-4709, investor@natera.com
Media: Lesley Bogdanow, VP of Corporate Communications, Natera, Inc., pr@natera.com
Source: Natera, Inc.